Cargando…
Amarogentin Inhibits Liver Cancer Cell Angiogenesis after Insufficient Radiofrequency Ablation via Affecting Stemness and the p53-Dependent VEGFA/Dll4/Notch1 Pathway
BACKGROUND: Whether and how amarogentin suppresses the angiogenesis effect in liver cancer cells after insufficient radiofrequency ablation (iRFA) are still poorly studied. METHODS: The number of liver cancer stem cells (LCSCs) and the level of vascular endothelial growth factor A (VEGFA) were asses...
Autores principales: | Zhang, Yongchuan, Zhang, Yinglin, Wang, Jin, Gu, Haitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596460/ https://www.ncbi.nlm.nih.gov/pubmed/33145353 http://dx.doi.org/10.1155/2020/5391058 |
Ejemplares similares
-
Insufficient Radiofrequency Ablation Promotes Angiogenesis of Residual Hepatocellular Carcinoma via HIF-1α/VEGFA
por: Kong, Jian, et al.
Publicado: (2012) -
Dll4-Notch signaling as a therapeutic target in tumor angiogenesis
por: Kuhnert, Frank, et al.
Publicado: (2011) -
MPDZ promotes DLL4-induced Notch signaling during angiogenesis
por: Tetzlaff, Fabian, et al.
Publicado: (2018) -
Tryptanthrin inhibits tumor angiogenesis via Notch/Dll4 signaling pathway in zebrafish
por: Lin, Meimei, et al.
Publicado: (2023) -
Inhibition of Dll4/Notch1 pathway promotes angiogenesis of Masquelet’s induced membrane in rats
por: Tang, Qian, et al.
Publicado: (2018)